secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2023-07-14T23:59:59+00:00
Accession:  0001213900-23-057132
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics closes $7.5 million private placement of common stock and warrants
--------------------------------------------------------------------------------

- Closed offering of 4,285,715 shares (or pre-funded warrants) at $1.75 per share, raising ~$7.5M gross.
- Issued warrants to purchase 4,285,715 shares at $1.75, exercisable for 5.5 years from issuance.
- Net proceeds to be used for working capital to advance tecarfarin development.
- Directors and officers subject to 60-day lock-up after registration statement effectiveness.
- Placement agent H.C. Wainwright; Boustead Securities acted as financial advisor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390023057132/0001213900-23-057132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390023057132/ea181825-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-057132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer